PT Kalbe Farma Tbk
PTKFF
Market Cap$4.34B
Close$
$0.00
95.8% downside
Current Fair Value
95.8% downsideOvervalued by 95.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.34 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $31.0 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | 0.0 |
| Outstanding Shares | 46,875,122,110 |
| Avg 30 Day Volume | 1,277 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About PT Kalbe Farma Tbk
CEO: Vidjongtius PT Kalbe Farma Tbk engages in the development, distribution, and trading of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. T...